CVAC
$54.17
Curevac N.V.
($.91)
(1.65%)
CVAC
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.76)
Revenue:  N/A
Thursday
Apr 15
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when CVAC reports earnings?
Beat
Meet
Miss

Where is CVAC's stock price going from here?
Up
Flat
Down
Stock chart of CVAC
Analysts
Summary of analysts' recommendations for CVAC
Score
Grade
Pivots
Resistance
$58.25
$56.85
$55.51

$54.10

Support
$52.76
$51.36
$50.02
Tweet
Growth
Description
CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.